Anti-centromere antibody is an independent risk factor for chronic kidney disease in patients with primary biliary cirrhosis

作者：Mandai Shintaro^*; Kanda Eiichiro; Arai Yohei; Hirasawa Suguru; Hirai Toshiyuki; Aki Shota; Inaba Naoto; Aoyagi Makoto; Tanaka Hiroyuki; Ikeda Takaaki; Tamura Teiichi; Sasaki Sei

来源：Clinical and Experimental Nephrology, 2013, 17(3): 405-410.

DOI：10.1007/s10157-012-0724-1

• Anti-centromere antibody
• Chronic kidney disease
• Primary biliary cirrhosis
• Systemic sclerosis

Anti-centromere antibody (ACA), a typical autoantibody of systemic sclerosis, is also detected in primary biliary cirrhosis (PBC). However, its pathogenic role is not fully understood. The aim of this study was to determine the association between ACA and kidney function in PBC. %26lt;br%26gt;A cohort of 37 patients diagnosed as having PBC from July 2001 to November 2011 at Yokosuka Kyosai Hospital was retrospectively analyzed for a follow-up period of 12 months. The annual rate of estimated glomerular filtration rate (eGFR) decline within 1 year after the diagnosis was evaluated. The factors associated with eGFR decline were evaluated by linear regression analysis and logistic regression analysis. %26lt;br%26gt;Overall, 37 PBC patients were included, of whom 12 (32 %) had ACA. The patients with ACA had a lower eGFR (65.9 +/- A 19.9 vs. 80.3 +/- A 12.1 mL/min/1.73 m(2), P = 0.01), a higher likelihood of chronic kidney disease (CKD) (58 vs. 4 %, P = 0.0005), and a higher rate of annual eGFR decline (-4.3 +/- A 5.1 vs. 0.2 +/- A 4.6 mL/min/year, P = 0.01) than those without ACA. Univariate regression analysis and multivariate regression analysis adjusted for potential cofounders including age, eGFR, sex, diabetes mellitus, and hypertension showed that ACA was associated with eGFR decline (P = 0.011 and 0.017, respectively). Multivariate logistic regression analysis adjusted for these cofounders showed that ACA was associated with eGFR decline less than -4 mL/min/year (odds ratio 7.21, 95 % confidence interval 0.93-56.1, P = 0.059). %26lt;br%26gt;ACA is an independent risk factor for CKD in PBC. Evaluation of ACA and kidney function is necessary to prevent CKD progression in PBC patients.

• 出版日期2013-6